http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2334355-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f73a8d824f0bb76033ff0d97e34355d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
filingDate 1999-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6996667ab9404de304a1a9f74729760c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08ad4df7dbb281ce557bd68244639090
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf592c3d9f8faecb24843a78a10e580c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e07240f4559038bab3d9f1a2f346ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbe587e2ad6609ca7d05696f9b20a2b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31f327aaadc38818bd5a238d7b321d56
publicationDate 1999-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2334355-A1
titleOfInvention Prostaglandin derivatives
abstract A prostaglandin derivative represented by the formula: wherein X is a halogen atom, n is an integer of 1 to 5, R1 is a C3-10 cycloalkyl group, a C3-10 cycloalkyl group substituted with C1-4 alkyl group(s), a C4-13 cycloalkylalkyl group, a C5-10 alkyl group, a C5-10 alkenyl group, a C5-10 alkynyl group or a bridged cyclic hydrocarbon group, and R2 is a hydrogen atom, a C1-10 alkyl group or a C3-10 cycloalkyl group, or a pharmaceutically acceptable salt thereof.
priorityDate 1998-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 26.